December 12, 2018
1 min read
Save

Sparing, standard surgical approaches yielded similar outcomes after TSA

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Young Kwon headshot
Young W. Kwon

Patients who underwent total shoulder arthroplasty with the subscapularis-sparing surgical approach had similar outcomes when compared with patients who underwent arthroplasty using the standard approach, according to results.

Young W. Kwon, MD, PhD, associate professor and director of clinical trials in the department of orthopedic surgery at NYU Langone Health, and colleagues randomly assigned 107 patients with end-stage osteoarthritis of the shoulder to undergo total shoulder arthroplasty (TSA) with either the subscapularis-sparing approach or the standard approach. Researchers collected VAS scores for pain, the American Shoulder and Elbow Surgeons outcome score and active motion of the affected shoulder preoperatively and at 3, 6, 12 and 24 months postoperatively.

At a mean follow-up of 31.1 and 33.4 months, researchers collected complete 2-year outcome data from 32 patients in the sparing group and 38 patients in the standard group, respectively. Results showed significant improvements in ASES and VAS scores in both groups, as well as no statistical significance between any differences. Researchers noted similar complication profiles between the two groups, with revision surgery during the study required in three patients in the sparing group and two patients in the standard group.

“In comparison to the traditional surgical approach for total shoulder replacement, this novel technique offers similar early clinical outcomes at 2 years after surgery,” Kwon told Healio.com/Orthopedics. “In addition to accelerated rehabilitation after surgery, we hope that this technique can potentially provide improved clinical outcomes in the future.” – by Casey Tingle

 

Disclosures: Kwon reports no relevant financial disclosures. Please see the full study for a list of all other authors’ relevant financial disclosures.